With all the articles we have posted about
for-profit medicine, we thought we ought to give time to what the davita has to say about this.
The following is what they gave us through contract lobbyists to answer our questions about their business:
http://dialysisethics2.org/open_images/flyers/Davita_answer.pdfThe above did bring up a couple of more questions that haven't been answered:
1) DaVita serves a large portion of the minority population. We recall the Afro-American dialysis population has a lower mortality rate than the Caucasian dialysis population. Shouldn't this cause
DaVita's mortality rate to be better than DCI's? Why the discrepancy?
2) We did see the improvement in lab results for phosphorous. Is this due more to the use of binders, or is it more time on dialysis? I do seem to recall phosphorous can be an indicator of middle molecule clearance and more time on dialysis - however it can also be cleared out with the use of binders.